BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 71 filers reported holding BELLICUM PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $14,403,000 | -23.4% | 1,057,512 | +11.9% | 0.00% | -25.0% |
| Q3 2016 | $18,810,000 | +64.3% | 945,216 | +7.0% | 0.00% | +33.3% |
| Q2 2016 | $11,446,000 | +119.4% | 883,201 | +58.3% | 0.00% | +200.0% |
| Q1 2016 | $5,216,000 | -51.9% | 557,813 | +4.2% | 0.00% | -66.7% |
| Q4 2015 | $10,850,000 | +237.1% | 535,292 | +141.6% | 0.00% | +200.0% |
| Q3 2015 | $3,219,000 | -31.5% | 221,543 | +0.3% | 0.00% | 0.0% |
| Q2 2015 | $4,698,000 | -13.4% | 220,886 | -5.6% | 0.00% | 0.0% |
| Q1 2015 | $5,422,000 | – | 234,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 220,000 | $5,069,000 | 3.43% |
| Perceptive Advisors | 1,046,402 | $24,109,000 | 2.02% |
| Redmile Group, LLC | 860,809 | $17,269,000 | 1.88% |
| Baker Brothers Advisors | 4,283,732 | $98,697,000 | 1.01% |
| RA Capital Management | 1,026,402 | $9,337,000 | 1.00% |
| Ghost Tree Capital, LLC | 75,000 | $1,728,000 | 0.83% |
| ACUTA CAPITAL PARTNERS, LLC | 45,750 | $1,054,000 | 0.71% |
| GREAT POINT PARTNERS LLC | 50,000 | $1,152,000 | 0.55% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 167,210 | $3,853,000 | 0.33% |
| EMERALD ADVISERS, LLC | 198,202 | $4,567,000 | 0.24% |